First Bight Ventures is an early-stage fund focused on synthetic biology startups, targeting the emerging BioEconomy sector. The firm typically invests in seed-stage rounds, supporting innovative companies at the forefront of biological engineering and its applications across various industries.
Notable portfolio companies include Algenesis, which has raised $5 million, and Persephone Biosciences, with $15 million in total funding. First Bight Ventures aims to capitalize on the potential trillion-dollar BioEconomy market, aligning with industry leaders' visions for the sector's growth and impact on humanity. The firm keeps stakeholders informed through its monthly newsletter, Focus First Bight, covering portfolio updates, industry trends, and relevant events.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.
